Metraipolis › archive › dc_df41fb1d0611

Unified platform for genetic and serological detection of COVID-19 with single-molecule technology — Europe PMC PMID:34310620

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/34310620
DOI
10.1371/journal.pone.0255096
License (as archived)
CC0-1.0
Archived
2026-11-03T12:58:06.786Z
SHA-256 of the archived text
711a62f0caf6be3a9f6c1145834b44aa988ee6ed4f2db71ca648f019c8595f6d
Stable URL of this page
https://metraipolis.com/documento/dc_df41fb1d0611

How to cite

Unified platform for genetic and serological detection of COVID-19 with single-molecule technology — Europe PMC PMID:34310620 — Europe PMC (en), https://europepmc.org/article/MED/34310620 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_df41fb1d0611 (Metraipolis archive dc_df41fb1d0611, sha256 711a62f0caf6be3a9f6c1145834b44aa988ee6ed4f2db71ca648f019c8595f6d)
BibTeX
@misc{dcdf41fb1d0611,
  title = {Unified platform for genetic and serological detection of COVID-19 with single-molecule technology — Europe PMC PMID:34310620},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/34310620},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_df41fb1d0611; sha256 711a62f0caf6be3a9f6c1145834b44aa988ee6ed4f2db71ca648f019c8595f6d},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34310620. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

The COVID-19 pandemic raises the need for diverse diagnostic approaches to rapidly detect different stages of viral infection. The flexible and quantitative nature of single-molecule imaging technology renders it optimal for development of new diagnostic tools. Here we present a proof-of-concept for a single-molecule based, enzyme-free assay for detection of SARS-CoV-2. The unified platform we developed allows direct detection of the viral genetic material from patients' samples, as well as their immune response consisting of IgG and IgM antibodies. Thus, it establishes a platform for diagnostics of COVID-19, which could also be adjusted to diagnose additional pathogens.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-07-26).
Identificativi: PMID 34310620 · PMCID PMC8312974 · DOI 10.1371/journal.pone.0255096.
Pagina: https://europepmc.org/article/MED/34310620 — https://doi.org/10.1371/journal.pone.0255096. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-03T12:49:41.818Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.